Buy The Dip On The FTC’s Latest Victim Forbes – Markets

Buy The Dip On The FTC’s Latest Victim Forbes – Markets

Shares of Horizon Therapeutics (HZNP) are fresh off their lowest level since November, after the Federal Trade Commission (FTC) yesterday said it will block the acquis…

Read More